Pre-eclampsia-related TLR2/4 signaling activates NOX2/4 to induce oxidative stress and ferroptosis in trophoblasts Authors: Yan Zhang, Yunmei Ke, Baosheng Zhu, Zhuo Chen, Li Ren, Jinman Zhang, Jie Wu Published: 2025 ABSTRACT AbstractBackgroundOxidative stress and ferroptosis have been recognized as detrimental factors in trophoblast malfunction in pre-eclampsia (PE). Here, we investigated the roles of toll-like receptor (TLR) signaling in PE-induced ferroptosis in the placenta tissues and explored the therapeutic potential of targeting TLR signaling in the animal model of PE.MethodsPlacental tissues from 20 PE patients and 20 healthy controls were analyzed for TLR2/4 expression and MAPK signaling activation using Western blot and transmission electron microscopy. HTR-8/SVneo trophoblasts were subjected to hypoxia/reoxygenation (H/R) induction to mimic PE conditions. Cell proliferation (CCK-8 assay), migration (scratch assay), invasion (transwell assay), and angiogenesis (tube formation assay) were assessed. Ferroptosis markers were evaluated by Western blot, and oxidative stress parameters including reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and labile iron were measured using commercial kits. In vivo, a reduced uterine perfusion pressure (RUPP) rat model of PE (n = 6 per group) was established on gestational day 14, and animals were treated with robinin (TLR2/4 inhibitor, 5 mg/kg/day) or VAS2870 (NADPH oxidase [NOX] inhibitor, 5 mg/kg/day) via intraperitoneal injection. Blood pressure, proteinuria, coagulation parameters, and placental ferroptosis markers were analyzed on gestational day 18.ResultsTLR2/4 upregulation and mitogen-activated protein kinase (MAPK) signaling over-activation were found in the placental tissues of PE patients and in H/R-induced trophoblasts. Inhibiting TLR2/4 reduced MAPK signaling and improved trophoblast proliferation, migration, invasion, and angiogenesis. TLR2/4-dependent NADPH oxidase 2 and 4 (NOX2 and NOX4) upregulation contributed to the oxidative stress and ferroptosis in trophoblasts upon H/R induction. In the rat model of PE, inhibiting TLR2/4 and NOX activity prevented ferroptotic events in the placental tissues and ameliorated PE syndromes, including elevated blood pressure and proteinuria.ConclusionsTLR2/4-dependent oxidative stress and ferroptosis may undermine trophoblast function in the PE placenta, and targeting TLR signaling-mediated ferroptosis could serve as an intervention strategy of PE.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40001-025-03637-6.Keywords: Pre-eclampsia, Trophoblasts, Toll-like receptor (TLR), Oxidative stress, Ferroptosis Introduction Pre-eclampsia (PE) is a commonly diagnosed disorder in pregnant women. It is characterized by high blood pressure (systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg) and is associated with the onset of at least one of the following conditions: proteinuria, maternal organ dysfunction (involving the liver, neurological system, hematological system, or kidneys), or uteroplacental dysfunction [1, 2]. These symptoms typically occur at or after 20 week gestation [1, 2]. Severe PE may endanger the lives of the mother and infant, which accounts for a global incidence rate of 3–5% [3, 4]. The etiology of PE is quite complex, and multiple factors such as chronic hypertension, pregestational diabetes, autoimmune diseases and abnormally high prepregnancy body mass index could all contribute to the increased risk of PE [5, 6]. Previous studies have suggested that the abnormal proliferation, differentiation, infiltration, and apoptosis of placental trophoblasts in PE patients could lead to defects of placental vascular remodeling, culminating in ischemia and hypoxia of placental tissues [7, 8].Placental development defect due to insufficient infiltration of trophoblastshas been recognized as the main cause of PE [9]. PE can lead to serious consequences, such as maternal morbidity and adverse outcomes for the fetus, including intrauterine growth restriction, preterm birth, fetal distress, and fetal death in utero [10]. In addition, PE pregnancies are characterized by inflammation, oxidative stress, and metabolic dysfunctions [11–13]. Deciphering the mechanisms governing trophoblast differentiation and migration can shed light on the formulation of novel intervention strategies for PE management [14]. Ferroptosis is a newly recognized cell death modality implicated in different pathophysiological conditions. For example, ferroptosis induced by oxidative stress can lead to detrimental tissue damages in ischemia/reperfusion conditions, which involves iron-dependent production of reactive oxygen species (ROS) [15]. The suppression of ferroptosis has been proposed as a potential therapeutic approach to alleviate H/R-induced injuries [16]. Several hallmarks have also been recognized as indicators of ferroptosis, including the over expression of prostaglandin endoperoxide synthase 2 (PTGS2), elevated malonaldehyde (MDA) and lipid ROS levels, and mitochondria damages [17]. To prevent undesirable ferroptosis, glutathione peroxidase 4 (GPX4) serves as a protector against ferroptosis by antagonizing lipid peroxides and ferritin heavy chain (FTH) could bind to free iron to limit excessive free radicals production [18]. Emerging evidence also suggest that ferroptosis may contribute to the functional impairment of placental tissues in PE [19]. Nevertheless, how these ferroptosis regulators become deregulated in the trophoblasts and placental tissues after ischemia in PE patients remains to be clarified. Toll-like receptors (TLRs) are evolutionarily conserved family of pattern recognition receptors [20]. Apart from playing the key roles in the immune defense against bacterial and viral infections, the deregulation of TLR signaling is also implicated in development of various disorders, including arteriosclerosis, cancer, and metabolic syndrome [21]. Recent evidence implies that aberrant placentation in PE patients is associated with increased expression of TLRs [22]. For example, the expression levels of TLR-2, TLR-3, TLR-4 and TLR-9 were reported to be increased in placentas from PE patients [23]. Abnormal activation of TLR2/4 signaling could alter the inflammatory phenotype of monocytes in PE patients, which impacts on the adhesive and angiogenic potential of endothelial cells [24]. Besides, TLR signaling could trigger the activation of mitogen activated protein kinase pathway (MAPK), including the phosphorylation of different kinases (JNK/p38/ERK) [25, 26]. The excessive activation of MAPK signaling may lead to mitochondrial defects and ROS generation [27, 28]. The potential role of TLR signaling activation in triggering placental ferroptosis warrants further investigation. This study aims to clarify the role of TLR signaling in PE-induced ferroptosis in the placenta and investigate the therapeutic potential of targeting TLR signaling in the rat model of PE. We compared the expression levels of TLR2/4 and the MAPK signaling activation in the placental tissues from healthy control and PE patients. The role of TLR2/4 and the MAPK signaling in ischemia-induced ferroptosis was investigated in the trophoblasts with hypoxia/re-oxygenation induction. We also explored the therapeutic potential of targeting TLR2/4-mediate ferroptosis in the rat model of PE. Materials and methods Subject recruitment A total of 166 pregnant women were initially recruited during their first prenatal visit (before 12 week gestation) at The First People's Hospital of Yunnan Province between January 2021 and December 2022. Blood samples (10 mL) were collected from each subject during routine prenatal visits in the first (11–13 weeks), second (24–28 weeks), and third trimester (34–36 weeks). Blood collection was performed in the morning after overnight fasting. Samples were drawn from the antecubital vein using standard venipuncture technique with subjects in a seated position. Blood was collected into anti-coagulation tubes and serum separator tubes. The samples were allowed to clot for 30 min at room temperature before centrifugation at 3000g for 15 min at 4 °C. The separated serum was aliquoted into cryovials and stored at − 80 °C until analysis. Additional blood samples were collected at the time of delivery following the same procedure. For each collection timepoint, samples were processed within 4 h of collection. After applying inclusion/exclusion criteria and matching for age, 20 healthy pregnant females and 20 pregnant females who later developed PE syndromes were included in the final analysis. The inclusion criteria for the PE group were: 1. systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg after 20 weeks of gestation; 2. proteinuria ≥ 0.3 g/24 h; 3. single pregnancy; and 4. no other pregnancy complications. The exclusion criteria were: 1. pregnancy-induced hypertension; 2. chronic hypertension; and 3. chronic hypertension with PE. The inclusion criteria for the control group were: single pregnancy and term pregnancy without any complications. The PE group was diagnosed according to the inclusion criteria after 20 week gestation. Early pregnancy samples from these subjects were analyzed retrospectively after their PE diagnosis. Immediately after delivery, placental samples were collected from women who underwent elective cesarean section without labor to minimize contamination risk and ensure placental functional integrity. The samples were rinsed with physiological saline and stored at − 80 °C until further analysis. The study was approved by the medical research ethics committee of The First People's Hospital of Yunnan Province (approval number: 2020KY5070). All subjects provided written informed consent. Biomedical indicator analyses Intravenous blood samples (10 mL) were harvestedusing a sterile 5/8-inch-long 25 gauge needle and 15 mL syringe, and collected into an anti-coagulation tube (Noble Ryder Technology, Beijing, China). Prothrombin time (PT) and activated partial thromboplastin time (APTT) were measured via automated coagulation detection analyzer (Ryoto Viotech, Shenzhen, China) using 60 µL of blood samples. All blood samples were gently inverted 10 times every 5–10 min to prevent clot formation in the tubes and pipetted into the cartridges. The PT/APTT measurements were recorded along with corresponding sample collection size (0.1 vs. 0.5 mL). The plasma ferritin level was examined using an ELISA detection kit (Weber Technology, Guangzhou, China). Total urine proteins were measured using urine protein ELISA detection reagent (Sig Biotechnology, Shanghai, China). d-dimer (D–D) was detected via D2D ELISA assay kit (Weisheng Biotechnology, Shanghai, China). Cell culture and treatment HTR-8/SVneo cells were obtained from the Type Culture Collection of the Chinese Academy of Sciences (Beijing, China), and the cell line was screened for mycoplasma contamination by PCR test and monitored for cross-contamination through STR profiling by the supplier. HTR-8/SVneo cells were cultured in RPMI-1640 medium (11875093, Invitrogen, Salt Lake City, UT, USA) supplemented with 10% FBS (F4135, Sigma, Munich, Germany) and 1 × penicillin–streptomycin antibiotics (P4333, Sigma, Munich, Germany). Cell culture was incubated under 37 °C with 5% CO2. Hypoxia/re-oxygenation (H/R) was induced in the trophoblasts to mimic PE-induced stress. To induce hypoxia, cells were incubated in a culture chamber filled with 5% CO2 and 95% N2 for 8 h. After the incubation, the cells were transferred into an incubator with 5% CO2 and 95% air for 24 h re-oxygenation. Robinin (TLR2/4 inhibitor, HY-N1346) and VAS2870 (NOX inhibitor, HY-12804) were purchased from MedChemExpress (Shanghai, China). The concentration used for Robinin (10 μM) was selected based on the official website information, at which no significant toxicity was induced but show inhibition towards the target. RT–qPCR analysis Total RNA was extracted from cells or tissues using TRIzol reagent (15596026, Invitrogen, Salt Lake City, UT, USA) following the manufacturer's protocol. RNA concentration and quality were assessed using NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). One microgram of total RNA was reverse transcribed into cDNA using PrimeScript RT reagent Kit (RR037A, Takara, Kusatsu, Japan). Quantitative PCR was performed using SYBR Green PCR Master Mix (4,309,155, Applied Biosystems, Foster City, CA, USA) on a QuantStudio 5 Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA). The PCR cycling conditions were: 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. GAPDH was used as internal control. Relative gene expression was calculated using the 2^(-ΔΔCt) method. Primers used for qPCR: GAPDH: Forward GGAGCGAGATCCCTCCAAAAT; Reverse GGCTGTTGTCATACTTCTCATGG; HLA-G: Forward: CACGCACAGACTGACAGAATG; Reverse GCCATCGTAGGCATACTGTTCA; CGB: Forward TGAGCATGGGCGGGACA; Reverse GCACAGATGGTGGTGTTGACG. CCK-8 proliferation assay The CCK-8 cell proliferation kit (CA1210, Solarbio, Beijing, China) was used to evaluate the cell growth under different experimental conditions. Each well in the 96-well plates was inoculated with 2,000 cells, and the cells were cultured for different durations with or without chemical or H/R treatment. Then, 10 μL CCK8 reagent was added to the cell culture at indicated timepoint and incubated for 3 h in the incubator. The light absorption value (OD value) in each condition was captured at 450 nm wavelength on a Synergy H1 microplate reader (Winooski, WI, USA). Scratch and transwell invasion assay The scratch and transwell assays were applied to determine the invasive and migratory ability. For scratch assay, trophoblasts were plated in a 6-well plate until 80% confluence. A scratch was established on the cell monolayer with as sterile tip. Cells were cultured for 24 h and a light microscope (Leica, Wetzlar, and Germany) was used to record the distance of the wound. In transwell invasion analysis, the transwell cassette (3422, Corning, Corning, NY, USA) coated with Matrigel (356234, Corning, Corning, NY, USA) was inoculated with 2 × 105 cells (in serum-free medium) in the upper part. The lower cassette was filled with complete medium. After 24 h incubation, the invading cells on the membrane were detected under a microscope at 200 × magnification. In vitro tube formation assay An in vitro angiogenesis assay kit (ab204726; Abcam, Cambridge, UK) was used to analyze the angiogenic potential of trophoblasts. 40 μL extracellular matrix gel (356234, Corning, Corning, NY, USA) was added to each well of a 96-wellplate and the plate was incubated at 37 °C for 15 min. Cells (2.0 × 104) in the complete medium were added to each well and incubated for 18 h. The cell morphology was observed with a phase-contrast microscope (Leica, Wetzlar, Germany). The Image J Angiogenesis Analyzer (National Institutes of Health (NIH), Bethesda, MD, USA) was used for quantification of the network structure and the number of branches. Detection of ROS, labile iron concentration, glutathione (GSH) and malondialdehyde (MDA) Intracellular redox status was determined using the ROS concentration measurement kit (R0105, Jiancheng Bioengineering Institute, Nanjing, China) based on the supplier’s instructions. The labile iron concentration was assayed using the Iron Assay kit (ab83366, Abcam, Cambridge, UK). GSH detection kit (S0053, Beyotime Biotechnology, Beijing, China) and MDA measurement kit (S0131M, Beyotime Biotechnology, Beijing, China) were used for GSH and MDA measurement following the manufacturer's instructions. A BCA Protein assay kit (P0009, Beyotime Biotechnology, Beijing, China) was used to quantify the amount of total protein in each sample for normalization. Lactate dehydrogenase (LDH) assay LDH activity in the cell culture supernatant was determined using a Lactate Dehydrogenase Assay kit (C0016, Beyotime Biotechnology, Beijing, China). Briefly, LDH assay buffer and LDH substrate were added into each standard of LDH protein, the positive control, and the supernatant from each sample. Standard wells = 50 µL standard dilutions; Sample wells = 50 µL samples (adjust volume to 50 µL/well with LDH Assay Buffer); Positive control = 5 µL Positive control and adjust volume to 50 µL/well with LDH Assay Buffer. 50 µL of Reaction Mix was added into each standard, sample and positive control sample well. After gentle mix, the output was measured immediately at OD 450 nm using a microplate reader. Western blot The protein extraction kit (20127ES, Yeasen Biotechnology, Shanghai, China) was used to extract total protein sample from cultured cells or tissues. The protein concentration was determined using a BCA assay kit (P0009, Beyotime Biotechnology, Beijing, China). 10 μg of protein was analyzed using 12% polyacrylamide gels, and then deposited to polyvinylidene fluoride (PVDF) membranes (F019533-0001, Sangon Biotech, Shanghai, China). The membranes were blocked with 5% nonfat milk at room temperature for 1 h, and then treated overnight at 4 °C with the primary antibodies against the target proteins. After washing, the membrane was further labeled with the detection secondary antibody for 1 h at ambient temperature. A Beyo ECL Star kit was employed to detect the protein bands (P0018S, Beyotime Biotechnology, Beijing, China). The following antibodies were used (Abcam): the following antibodies were used (Abcam): anti-β-actin (ab8227, 1:2500), anti-NOX2 (ab310337, 1:1500), anti-NOX4 (ab109225, 1:1000), anti-TLR2 (ab213676, 1:1000), anti-TLR4 (ab22048, 1:1000), anti-FTH1 (ab65080, 1:1000), anti-p-ERK1/2 (ab76299, 1:1000), anti-p-P65 (ab76302, 1:1000), anti-p-P38 (ab178867, 1:1000), anti-p-JNK (ab307802, 1:1000), anti-GPX4 (ab41787, 1:1000), anti-PTGS2 (ab15191, 1:1000), anti-cytokeratin 7 (ab181598, 1:500), anti-hCG beta (ab317567, 1:1000), anti-HLA-G (ab7758, 1:1000), anti-rabbit IgG HRP (ab6721, 1:5000), and goat anti-mouse IgG HRP (ab97023, 1:5000). Transmission electron microscope (TEM) Placental villi where trophoblasts are the predominant cell type were fixed in 2.5% glutaraldehyde solution (4 °C) overnight, and then washed using PBS and 1% osmium tetroxide solution was added for 1 h incubation at ambient temperature. After dehydration, the samples were placed into pure acetone mixture and embedded in epoxy resin and ultra-microsectioned. The ultra-thin sections were stained with uranyl acetate and lead citrate, and observed under an electron transmission microscope (Hitachi HT7800, Tokyo, Japan). Rat model of PE A rat model of PE was established by the Reduced Uterine Perfusion Pressure (RUPP) method. Briefly, female Sprague–Dawley rats on gestational day 10 (GD10) were received from Cyagen (Jiangsu, China) and housed in the animal research facility. Placental ischemia was induced by RUPP on GD 14. The rats were assigned into the sham (control) and RUPP groups randomly. The RUPP group rats were anesthetized (~ 3% isoflurane in 2 L/min O2). The uterus was exposed and silver clip (0.203 mm ID) was placed around the aorta above the iliac bifurcation and the branches of the ovarian arteries. In the sham group, the uterus was exteriorized without clipping the aorta above the iliac bifurcation. In the drug treatment group, the RUPP rats were administrated with Robinin (TLR2/4 inhibitor, 5 mg/kg/day) or VAS2870 (NOX inhibitor, 5 mg/kg/day) by intraperitoneal injection. There were 6 rats assigned in each experimental group. On GD 18, the blood pressure was measured and the biochemical analyses of blood samples were conducted. The rats were sacrificed and the placental tissues were collected for further analysis. The animal protocols were approved by the animal use and welfare committee of Kunming University of Science and Technology Laboratory Animal Center (approval number: 2020KY5069). Statistics Statistical analyses were conducted using GraphPad Prism Version 8.0 (GraphPad software, NY, USA). Student's t test and analysis of variance (ANOVA) were applied to compare the data of two groups or multiple groups, respectively. Comparisons of data at multiple timepoints were performed using two-way ANOVA. Data were summarized as the mean ± standard deviation. P < 0.05 was selected as the statistical threshold of significance. Results Upregulation of TLR2/4 and ERK signaling in the placental samples from PE patients After applying inclusion/exclusion criteria and matching for age, 20 healthy pregnant females and 20 pregnant females who later developed PE syndromes were included in the final analysis. The two groups did not differ in terms of age, gravidity, parity, and pre-pregnancy body mass index. However, it is worth noting that the control group had a significantly higher total gestational weeks compared to the PE group (Table 1). Compared to the healthy controls, the blood pressure level were significantly elevated and PT were significantly decreased in PE patients. There was no significant difference of serum ferritin levels between PE and healthy groups at first trimester; But as the gestational age increases, the ferritin levels were significantly higher in second and third trimester PE patients when compared to those of the healthy group (Fig. 1A–D). To determine the impact of PE on the placenta tissues, we collected the placental samples from the healthy controls and PE patients after the delivery. Western blot was conducted to analyze the changes in the expression of TLR2/4 and the activation state of ERK signaling. Both TLR2 and TLR4 showed a significant upregulation in the placental samples from PE group, which was accompanied by the enhanced phosphorylation of ERK1/2, P65, p38, and JNK kinases (Fig. 1E). These data demonstrate that PE is associated with elevated levels of TLR2/4 and increased activation of ERK signaling in the placental tissues. Table 1Clinical data of two groups of subjectsControlPEZ/tPn2020Age31.2 ± 4.8332.45 ± 4.85− 0.9030.372Gravidity1.5(1–3)1.5 (1–3.75)− 0.7890.430Parity0.5 (0–1)0 (0–1)− 0.9390.348Pre-pregnancy body mass index21.12 ± 2.8723.09 ± 2.87− 2.1760.036Gestational weeks39.22 (38.85–40.07)33.22 (29.72–36.29)− 4.219 < 0.001Neonatal weight3246.75 ± 273.251821.5 ± 494.36− 11.28 < 0.001MAP86.7 ± 7.62125.58 ± 9.1− 14.65 < 0.001Percentile44.2 ± 22.986.16 ± 9.51− 6.842 < 0.001Data are presented as mean ± standard deviation or median (interquartile range). PE, pre-eclampsia; BMI, body mass index. Statistical comparisons were performed using Student's t test for normally distributed data (age, pre-pregnancy BMI) or Mann–Whitney U test for non-normally distributed data (gravidity, parity, gestational weeks) Clinical data of two groups of subjects Data are presented as mean ± standard deviation or median (interquartile range). PE, pre-eclampsia; BMI, body mass index. Statistical comparisons were performed using Student's t test for normally distributed data (age, pre-pregnancy BMI) or Mann–Whitney U test for non-normally distributed data (gravidity, parity, gestational weeks) Upregulation of TLR2/4 and ERK signaling in the placental samples from PE patients. The summary of diastolic blood pressure (A), systolic blood pressure (B), prothrombin time (PT) (C), serum ferritin level (D) in the healthy controls and PE patients. Western blot analysis of the protein levels of TLR2/TLR4 and the phosphorylation levels of ERK1/2, P65, P38, and JNK kinases in the placental tissues of healthy control and PE groups (E). A–D n = 20 subjects in each group; E 3 samples from each group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 Ferroptosis cell features in the placental tissues of the PE group Next, we determined whether ferroptosis potentially contributes to the defect in the placental tissues of the PE patients. Transmission electron microscope (TEM) analysis of placental villi, where trophoblasts are the predominant cell type revealed that the mitochondria in the PE placenta displayed disrupted cristea (Fig. 2A), which has been recognized as a key feature of ferroptosis. Meanwhile, the analysis of ferroptosis markers showed that PTGS2 was heavily up-regulated in the placental tissue of the PE group, while GPX4 and FTH1 were down-regulated (Fig. 2B). In addition, the analysis of the ROS-generating proteins also revealed the upregulation of NOX2 and NOX4 in the placental tissue of the PE group. Thus, ferroptosis is potentially implicated in the defect of placental tissues in the PE patients. Ferroptosis cell features in the placental tissues of the PE group. Transmission electron microscope (TEM) analysis of the sub-cellular changes in the placental tissues of healthy controls and PE groups. For TEM analysis, placental villi from ten controls and ten PE subjects were examined. For each placenta, ten different fields were imaged for mitochondrial morphology assessment (A). Western blot analyses of ferroptosis markers GPX4, PTGS2, FTH1 and NOX2/4 in the placental tissues of healthy controls and PE groups, n = 3 samples in each group (B). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 Hypoxia–reoxygenation (H/R) impairs the cellular functions of trophoblasts To investigate the effects of PE on placental cell function, we established a hypoxia/reoxygenation (H/R) model using HTR8/SVneo human trophoblasts to simulate the reduced oxygen supply characteristic of PE placenta. We utilized the HTR8/SVneo cell line as our in vitro model, because it is derived from first-trimester human extravillous trophoblasts and exhibits key characteristics of trophoblast cells, including invasion and migration capacities that are critical for placental development and are impaired in PE. The H/R-treated cells showed significantly reduced proliferation compared to control cells (Fig. 3A). Importantly, H/R treatment did not induce significant cell death, as assessed by LDH release cytotoxicity assay (Fig. 3B). Furthermore, the expression of key trophoblast marker genes CGB1 (Chorionic Gonadotropin Beta 1) and HLA-G (Human Leukocyte Antigen G) remained stable under H/R conditions (Fig. 3C). These findings indicate that H/R treatment selectively impairs trophoblast proliferation while maintaining cell viability and trophoblast-specific identity. Hypoxia–reoxygenation (H/R) impairs the cellular functions of trophoblasts. HTR8/SVneo human trophoblasts were induced by H/R procedures to mimic the reduced oxygen supply to the placenta in the PE patients. CCK-8 proliferation assay (A), LDH release cytotoxicity assay (B), RT–qPCR measurement of trophoblast marker genes (C), scratch assay (D), transwell invasion assay (E), and In vitro tube formation assay (F) were performed in the control and H/R groups. Western blot analyses of TLR2/4, CGB1 and HLA-G expression, as well as the phosphorylation levels of ERK1/2, P65, p38, and JNK kinases (G). n = three biological samples from three independent experiments per group, each with three technical replicates for measurement (except for western blot analysis). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 The migration and invasion abilities (which are the critical features of trophoblasts) were also reduced in the H/R group (Fig. 3D, E). In vitro tube formation further revealed that the angiogenic potential of trophoblasts were suppressed (Fig. 3F). We also analyzed the changes of TLR2/4 expression and ERK signaling upon H/R treatment. The results showed that H/R induction promoted the expression of TLR2 and TLR4 and enhanced phosphorylation levels of ERK1/2, P65, p38, and JNK kinases (Fig. 3G). Consistent with our qPCR data (Fig. 3C), CGB1 and HLA-G showed no significant changes at the protein levels following H/R treatment (Fig. 3G). This consistency between mRNA and protein expression provides robust evidence that H/R treatment does not affect the expression of these trophoblast markers in HTR-8/SVneo cells. Together, our data demonstrated that H/R induction impairs the cellular function of trophoblasts and activates TLR2/4 and ERK1/2 signaling. TLR2/4 inhibition partially rescues the functions of trophoblasts upon H/R induction We next sought to investigate whether the activation of TLR2/4 and ERK1/2 signaling contributes to the functional impairment of trophoblasts induced by H/R. To this end, cells with H/R induction was treated with robinin (TLR2/4 inhibitor, 10 μM). CCK-8 cell viability assays indicated that robinin below 30 μM did not affect cell viability (Figure S1), and therefore, we applied 10 μM for the intervention experiments. Robinin could suppress the upregulation of TLR2 and TLR4 upon H/R induction (Fig. 4A). The suppressed TLR2 and TLR4 expression also attenuated the phosphorylation of ERK1/2, P65, p38, and JNK kinases. Further functional experiments demonstrated that, TLR2/4 inhibition not only partially rescued cell proliferation upon H/R induction, but also enhanced the migration and invasion capacities of trophoblasts after H/R treatment (Fig. 4B–D). Bedsides, TLR2/4 inhibition also augmented the in vitro angiogenesis of trophoblasts after H/R induction (Fig. 4E). Therefore, the functional impairment of trophoblasts upon H/R induction could be at least partially attributed to the activation of TLR2/4 and ERK1/2 signaling. TLR2/4 inhibition partially rescues the functions of trophoblasts upon H/R induction. HTR8/SVneo human trophoblasts were induced by H/R procedures to mimic the reduced oxygen supply to the placenta in the PE patients. The H/R group was also treated with robinin (TLR2/4 inhibitor, 10 μM). Western blot analyses of TLR2/4 expression and the phosphorylation levels of ERK1/2, P65, p38, and JNK kinases (A). CCK-8 proliferation assay (B), scratch assay (C), transwell invasion assay (D), and in vitro tube formation assay were performed in the indicated experimental groups (E). n = three biological samples from three independent experiments per group, each with three technical replicates for measurement (except for western blot analysis). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 TLR2/4 inhibition protects against H/R-induced ferroptosis in trophoblasts Since we observed ferroptotic features in the placental tissues of PE patients, we next examined whether H/R procedures induced ferroptosis in trophoblasts and whether TLR2/4 upregulation is implicated in H/R-induced ferroptosis. First, the detection of ROS levels showed that there was an elevated oxidative stress upon H/R induction, and TLR2/4 inhibition mitigated ROS level (Fig. 5A). The analysis of lipid peroxidation byproduct MDA revealed that H/R-induced MDA levels were also attenuated upon TLR2/4 inhibition (Fig. 5B). The analysis of cell membrane integrity by LDH release assay suggested that H/R induction disrupted membrane integrity, while TLR2/4 inhibition protected against this detrimental effect (Fig. 5C). Besides, there was an increase of labile cellular iron concentrations and decreased levels of GSH in trophoblasts after H/R treatment; TLR2/4 inhibition reduced iron concentration and partially restored GSH levels in H/R-induced trophoblasts (Fig. 5D, E). Western blot analysis showed that NOX2 and NOX4 were induced by H/R and then suppressed with TLR2/4 inhibition, while the anti-ferroptotic proteins GPX4 and FTH1 showed the opposite trends (Fig. 5F). Together, these data imply that TLR2/4 inhibition protects against H/R-induced ferroptosis in trophoblasts. TLR2/4 inhibition protects against H/R-induced ferroptosis in trophoblasts. HTR8/SVneo human trophoblasts were induced by H/R procedures to mimic the reduced oxygen supply to the placenta in the PE patients. The H/R group was also treated with robinin (TLR2/4 inhibitor, 10 μM). The detection of ROS levels (A), the analysis of lipid peroxidation byproduct MDA levels (B), LDH release assay (C), the measurement of labile cellular iron concentrations (D), and the detection of GSH levels in each experimental group (E). Western blot analyses of NOX2, NOX4, GPX4 and FTH1 (F). n = three biological samples from three independent experiments per group, each with three technical replicates for measurement (except for western blot analysis). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 Increased NOX expression contributed to H/R-induced ferroptosis in trophoblasts As NOXs are the key ROS-generating enzymes and the oxidative stress could induce ferroptosis, we then attempted to determine whether the inhibition of NOXs could attenuate H/R-induced ferroptosis. The application of a potent NOX inhibitor VAS2870 could repress H/R-induced NOX2 and NOX4 upregulation, and promoted the expression of GPX4 and FTH1 upon H/R induction (Fig. 6A). As expected, NOX suppression attenuated the ROS production in trophoblasts upon H/R induction (Fig. 6B). NOX inhibition also reduced the MDA levels and free iron concentrations, and promoted the cellular GSH levels after H/R induction (Fig. 6C–E). LDH release assay suggested that NOX suppression could protect against H/R-induced cell membrane disruption in trophoblasts (Fig. 6F). Therefore, the enhanced NOX expression and activity is a contributing factor to H/R-induced ferroptosis, which might be mediated by TLR2/4 and ERK1/2 signaling. Increased NOX expression contributed to H/R-induced ferroptosis in trophoblasts. HTR8/SVneo human trophoblasts were induced by H/R procedures to mimic the reduced oxygen supply to the placenta in the PE patients. The H/R group was also treated with VAS2870 (NOX inhibitor, 10 μM). Western blot analyses of NOX2, NOX4, GPX4 and FTH1 (A). The detection of ROS levels (B), the analysis of lipid peroxidation byproduct MDA levels (C), the measurement of labile cellular iron concentrations (D), the detection of GSH levels (E) and LDH release assay in each experimental group (F). n = three biological samples from three independent experiments per group, each with three technical replicates for measurement (except for western blot analysis). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 TLR2/4 or NOX inhibition ameliorates PE syndromes and placental ferroptosis in the rat model To evaluate roles of TLR2/4 and NOX in PE development, we established a PE model in the pregnant rat. Compared to the control group, there was an elevation of the blood pressure, urine protein levels, and plasma D–D levels in the late pregnant phase of rat model phase of PE group (Fig. 7A–C). The bleeding test also showed that there was a significant decrease in PT and APTT in the PE group (Fig. 7D, E). The above changes were partially reversed upon the inhibition of TLR2/4 or NOX (Fig. 7A–E). These data suggest that TLR2/4 or NOX inhibition ameliorates PE syndromes in the rat model. Western blot analysis of the placental tissue demonstrated the TLR2/4 inhibitor attenuated the expression of TLR2/4 and NOX2/4 in PE placenta, and NOX inhibition repressed NOX2/NOX4 levels, while TLR2/4 expression was not affected (Fig. 7F). These data indicate that NOX2 and NOX4 are downstream effectors regulated by TLR2/4. Both TLR2/4 and NOX inhibitors could restore GPX4 and FTH1 expression levels in PE placenta, and PTGS2 levels were inhibited by TLR2/4 and NOX inhibitors, suggesting the protection against PE-induced ferroptosis. We also analyzed the GSH levels and sub-cellular changes in the placental villi. TLR2/4 and NOX inhibitors could protect against PE-induced GSH depletion (Fig. 7G), and PE-associated mitochondrial defects in the placental villi were also rescued by TLR2/4 and NOX inhibitors (Fig. 7H). Together these data indicate the protective effect of TLR2/4 and NOX inhibitors on PE-induced ferroptosis in the placental tissues. TLR2/4 or NOX inhibition ameliorates PE syndromes and placental ferroptosis in the rat model. In a rat model of PE, robinin (TLR2/4 inhibitor) and VAS2870 (NOX inhibitor) were administrated as intervention (n = 6 animals in each group). The blood pressure (A), urine protein levels (B), plasma D–D levels (C), prothrombin time (PT) (D), and activated partial thromboplastin time (APTT) (E) were examined in each group. Western blot analyses of the expression levels of TLR2/4, NOX2/4, GPX4, FTH1 and PTGS2 in the placental tissues (F). GSH level detection in the placental tissues (G). Transmission electron microscope analyses of mitochondrial phenotypes in the placental villi (H). n = six biological samples from six animals per group, each with three technical replicates for measurement (except for western blot analysis). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 Discussion This study reveals a novel mechanistic link between TLR2/4 signaling activation and ferroptosis-mediated trophoblast dysfunction in pre-eclampsia. Our integrated clinical, cellular, and animal model investigations demonstrate that TLR2/4 upregulation in PE placenta triggers MAPK signaling over-activation, which in turn drives NOX2/4-dependent oxidative stress and subsequent ferroptotic cell death in trophoblasts. Critically, pharmacological inhibition of either TLR2/4 or NOX activity not only prevented ferroptosis and restored trophoblast function in vitro, but also ameliorated key PE syndromes, including hypertension and proteinuria in vivo. These findings suggest the TLR2/4-NOX–ferroptosis axis as a central pathogenic mechanism in PE and identify targetable nodes for potential therapeutic intervention. Our data revealed the over expression of TLR2 and TLR4 in the placental tissues of PE patients, which was accompanied by the activation of MAPK signaling. TLRs are involved in the regulation of the innate immune responses of the maternal PE syndromes by triggering the inflammatory response [29]. For instance, previous evidence suggests that TLR4 is upregulated in the immune cells and placental tissues from pregnancy disorders, such as PE, which triggers the over-production of pro-inflammatory cytokines at the materno-fetal interface [30]. Aberrant placentation in PE patients is also associated with increased expression of TLR-2, TLR-3, TLR-4 and TLR-9 [22, 23]. Nevertheless, apart from undesirable immune responses, the impacts of TLR signaling activation on placental cells such as trophoblasts remain largely unknown. TLR signaling can activate MAPK signaling in different scenarios [31, 32]. Although MAPK signaling is essential for placental development [33], the over-activation of MAPK signaling is associated with pathological progression of different diseases, such as Alzheimer's disease, amyotrophic lateral sclerosis and various types of cancers [34]. Induction of p38-mediated MAPK signaling could lead to apoptosis in endometrial epithelial cells [35]. However, there is lack of knowledge regarding the effects of aberrant activation of MAPK signaling on trophoblasts. In this study, we showed that H/R-induced TLR and MAPK signaling activation caused functional impermanent in trophoblasts, including retarded cell growth, suppressed migration and invasion abilities, as well as reduced angiogenic potential. H/R-induced suppression in the proliferation and invasion of trophoblasts was previously reported [36, 37]. Since abnormal MAPK signaling can induce ROS generation in different scenarios [27, 28, 38, 39], the oxidative stress induced by the over-activation of TLR2/4-MAPK signaling may account for the functional defects in trophoblasts. In line with this, oxidative stress has been reported to disrupt trophoblast functions in PE placenta through the unfolded protein response [40]. In the clinical perspective, accumulating evidence suggests that increased oxidative burden appears to contribute to placental and endothelial dysfunction in PE and other pregnancy-related disorders [41]. Our data further demonstrated that H/R condition in the trophoblasts incurs the elevated ROS levels, which could be mitigated by TLR2/4 inhibitor. Thus, this study provides novel insights into the underlying mechanism of ROS over-production in ischemic trophoblasts. The aberrant upregulation of TLR2/4 and over-activation of MAPK signaling may be responsible for ROS production and the subsequent functional impairment of trophoblasts in the PE placenta. Another question is how TLR2/4-MAPK signaling induces oxidative stress in PE condition? Cellular ROS mainly comes from mitochondrial respiratory chain and the upregulation of NOX activities [42]. We showed that NOX2 and NOX4 were upregulated in PE placental tissues and H/R-induced trophoblasts. TLR2/4 inhibition could repress H/R-induced NOX2 and NOX4 over expression in trophoblasts, reduce ROS levels and also improve trophoblast function upon H/R induction. These data indicate that NOX2 and NOX4 may function as downstream effectors of TLR2/4 signaling to induce oxidative stress in PE placenta. These findings are also in agreement with the notion that NOX enzymes act downstream of TLR signaling to trigger ROS generation [43, 44]. Elevated oxidative stress can trigger ferroptosis in different pathophysiological conditions especially under ishcemia/reperfusion [45]. The induction of ferroptosis has also been linked to the lipotoxic damage in trophoblasts and adverse pregnancy outcome in PE patients [46]. Our clinical data revealed as the gestational age increases, the ferritin levels were significantly higher in second and third trimester PE patients when compared to those of the healthy group, suggesting that iron metabolism imbalance is involved in PE progression. We also observed ferroptotic features in the PE placental tissues, H/R-induced trophoblasts and the rat model of PE. Importantly, inhibiting TLR2/4 or NOX activity not only attenuated ROS production, but also protected against ferroptosis in the cell and animal model of PE. Furthermore, inhibiting TLR or NOX also alleviated PE syndromes in the rat model. Thus, the induction of ferroptosis by TLR2/4-NOX axis could undermine trophobalst and placental function in PE. Similarly, the over expression of TLR4 and NOX4 could promote ferroptotic cell death in heart failure [47]. TLR2 also induces ROS generation in monocytes through ERK/Nox-2 axis [48]. Together, our data highlight the critical roles of TLR2/4 activation in hypoxia-induced ferroptosis of trophoblasts, and provide novel insights into the therapeutic intervention of PE. Targeting TLR signaling mediated NOX upregulation could improve trophoblast function under ischemic condition, which may serve as an intervention strategy to ameliorate PE. Several limitations of the present study should be acknowledged. First, while our findings demonstrate the role of ferroptosis in H/R-induced trophoblast dysfunction using HTR8/SVneo cells, validation in other placental cell lines such as BeWo, JAR, or JEG-3 would strengthen the generalizability of our conclusions. Second, although our animal model recapitulates key features of PE, the complex pathophysiology of human PE may not be fully represented. While we focused on the TLR2/4-NOX axis in ferroptosis regulation, other potential pathways and mechanisms may contribute to PE pathogenesis. Moreover, this study primarily examined placental villi and trophoblast cells; the involvement of other cell types and maternal factors in PE development requires further investigation. Conclusion In summary, we reported the over expression of TLR2/4 and MAPK signaling over-activation in the placental tissues of PE patients and H/R-induced trophoblasts. Inhibiting TLR2/4 expression attenuated MAPK signaling and improved trophoblast functions after H/R induction. NOX2 and NOX4 upregulation seems to be responsible for TLR2/4 signaling-induced oxidative stress and ferroptosis in trophoblasts upon H/R. In the rat model of PE, TLR2/4 and NOX inhibitor protected against ferroptotic events in the placental tissues. These findings suggest targeting TLR signaling mediated ROS and ferroptosis as an intervention strategy of PE. Supplementary Information Supplementary Material 1: Figure S1. Effect of robinin on HTR8/SVneo cell viability. HTR8/SVneo cells were treated with increasing concentrations of robininfor 48 h, and cell viability was assessed by CCK-8 assay. Data are presented as mean ± SD of three independent experiments. Relative cell viability is expressed as a percentage of the control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Acknowledgements Not applicable. Author contributions Jie Wu and Jinman Zhang is responsible for the project planning, the fund support and the manuscript proofreading, Yan Zhang and Yunmei Ke completed the main experimental procedure, researched data and wrote the manuscript. Baosheng Zhu, Zhuo Chen and Li Ren researched data and contributed to the discussion. All authors contributed to the article and approved the submitted version. Funding This work was supported by the Combined Applied Scientific Research Projects of the Department of Science and Technology of Kunming Medical College (202101AY070001-264, 202101AY070001-242).National Health Commission Key Laboratory of Preconception Health Birth in Western China. National Natural Science Foundation of China (82260645). First people`s Hospital of Yunnan Province. Yunnan Province clinical Research Center for Gynecological and Obstetric Disease (2023YJZX-FC11); First people's Hospital of Yunnan province. National Key clinical specialty of Gynecology (2022FKZDZK-15); Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases (2024CSKFKT-02). Availability of data and materials The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. all methods were performed in accordance with the relevant guidelines and regulations. Declarations Ethics approval and consent to participate The study was approved by the medical research ethics committees of The First People’s Hospital of Yunnan Province (approval number: 2020KY5070). All the subjects signed the informed consent. The animal protocols were approved by the animal use and welfare committee of Kunming University of Science and Technology Laboratory Animal Center (approval number: 2020KYS069). Consent for publication All the subjects consented to this publication. Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Yan Zhang and Yunmei Ke are tied first authors and contributed equally to this work. Jinman Zhang and Jie Wu are co-corresponding authors. Contributor Information Jinman Zhang, Email: 171887587@qq.com. Jie Wu, Email: zhangyankmmc@163.com. References Associated Data Supplementary Materials Supplementary Material 1: Figure S1. Effect of robinin on HTR8/SVneo cell viability. HTR8/SVneo cells were treated with increasing concentrations of robininfor 48 h, and cell viability was assessed by CCK-8 assay. Data are presented as mean ± SD of three independent experiments. Relative cell viability is expressed as a percentage of the control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Data Availability Statement The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. all methods were performed in accordance with the relevant guidelines and regulations.